Kadcyla
IV Infusion
Roche Bangladesh Ltd.Generic:
Trastuzumab EmtansineWeight:
160 mg/vialbest Price:
? 150,500.00Generic
Trastuzumab Emtansine
Indications
Metastatic Breast Cancer (MBC): Trastuzumab Emtansine, as a single agent, is indicated for the treatment of patients with HER2-positive, unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
Side Effects
Patients treated with Trastuzumab Emtansine must have confirmed HER2-positive tumor status as assessed by either HER2 protein overexpression or gene amplification.
Pregnancy And Lactation
Pediatric Use: The safety and efficacy of Trastuzumab Emtansine in children below 18 years of age have not been established. Geriatric Use: There are insufficient data to establish the safety and efficacy of Trastuzumab Emtansine in patients 75 years of age or older.
Therapeutic
Anti neoplastic preparations
Storage Conditions
Store vials at 2�C-8�C.
Over The Counter Products
